Nasti, Tahseen H.

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., et al. (2016) · Nature

T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

Cited by 2,070

Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent

Kamphorst, A. O., Wieland, A., Nasti, T., Yang, S., Zhang, R., Barber, D. L., Konieczny, B. T., Daugherty, C. Z., Koenig, L., Yu, K., et al. (2017) · Science

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 1,015

Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients

Kamphorst, A. O., Pillai, R. N., Yang, S., Nasti, T. H., Akondy, R. S., Wieland, A., Sica, G. L., Yu, K., Koenig, L., Patel, N. T., et al. (2017) · Proceedings of the National Academy of Sciences

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 854

MC 1R, Eumelanin and Pheomelanin: Their Role in Determining the Susceptibility to Skin Cancer

Nasti, T. H., & Timares, L. (2015) · Photochemistry and Photobiology

melanin and skin pigmentationMelanoma and MAPK Pathways

Cited by 217

IL-23 Inhibits Melanoma Development by Augmenting DNA Repair and Modulating T Cell Subpopulations

Nasti, T. H., Cochran, J. B., Vachhani, R. V., McKay, K., Tsuruta, Y., Athar, M., Timares, L., & Elmets, C. A. (2017) · The Journal of Immunology

Cutaneous Melanoma Detection and ManagementT-cell and B-cell Immunology

Cited by 19